A pilot multi-centre randomised controlled trial of sequential treatment with mitoxantrone and glatiramer acetate vs. interferon beta1a in early active relapsing remitting multiple sclerosis
Phase of Trial: Phase III
Latest Information Update: 15 Jan 2018
At a glance
- Drugs Glatiramer acetate (Primary) ; Mitoxantrone (Primary) ; Interferon beta-1a
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 30 Jan 2009 Status changed from active, no longer recruiting to completed, according to ISRCTN: Current Controlled Trials.
- 01 Nov 2005 New trial record.